BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 26589514)

  • 1. [Molecular diagnosis of melanocytic tumors].
    Bauer J
    Hautarzt; 2016 Jan; 67(1):59-63. PubMed ID: 26589514
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Molecular diagnostic contribution in melanocytic lesions analysis (FISH/CGH)].
    de la Fouchardière A; Vergier B
    Ann Pathol; 2011 Nov; 31(5 Suppl):S115-6. PubMed ID: 22054446
    [No Abstract]   [Full Text] [Related]  

  • 3. Molecular diagnostics for ambiguous melanocytic tumors.
    Shahbain H; Cooper C; Gerami P
    Semin Cutan Med Surg; 2012 Dec; 31(4):274-8. PubMed ID: 23174498
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular biology methods to improve diagnosis and prognosis of melanocytic tumors.
    Wiesner T; Fried I; Cerroni L; Kutzner H
    J Dtsch Dermatol Ges; 2013 May; 11 Suppl 4():19-24. PubMed ID: 23721637
    [No Abstract]   [Full Text] [Related]  

  • 5. An Update Regarding the Molecular Genetics of Melanocytic Neoplasms and the Current Applications of Molecular Genetic Technologies in Their Diagnosis and Treatment.
    Kiavash K; Bluth MH; Thompson AD
    Clin Lab Med; 2018 Jun; 38(2):385-399. PubMed ID: 29776637
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of New Techniques in Addition to IHC Applied to the Diagnosis of Melanocytic Lesions, With Emphasis on CGH, FISH, and Mass Spectrometry.
    Nagarajan P; Tetzlaff MT; Curry JL; Prieto VG
    Actas Dermosifiliogr; 2017; 108(1):17-30. PubMed ID: 27344067
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Molecular diagnostics in melanoma].
    Lang R; Bauer JW; Laimer M
    Hautarzt; 2015 Apr; 66(4):277-81. PubMed ID: 25783213
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differentiation of malignant melanoma from benign nevus using a novel genomic microarray with low specimen requirements.
    Chandler WM; Rowe LR; Florell SR; Jahromi MS; Schiffman JD; South ST
    Arch Pathol Lab Med; 2012 Aug; 136(8):947-55. PubMed ID: 22849744
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fluorescence in situ hybridization as an ancillary method for the distinction of desmoplastic melanomas from sclerosing melanocytic nevi.
    Gerami P; Beilfuss B; Haghighat Z; Fang Y; Jhanwar S; Busam KJ
    J Cutan Pathol; 2011 Apr; 38(4):329-34. PubMed ID: 21323721
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular Melanoma Diagnosis Update: Gene Fusion, Genomic Hybridization, and Massively Parallel Short-Read Sequencing.
    Lang UE; Yeh I; McCalmont TH
    Clin Lab Med; 2017 Sep; 37(3):473-484. PubMed ID: 28802496
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular testing for melanocytic tumors: a practical update.
    Andea AA
    Histopathology; 2022 Jan; 80(1):150-165. PubMed ID: 34958511
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distinguishing melanocytic nevi from melanoma by DNA copy number changes: comparative genomic hybridization as a research and diagnostic tool.
    Bauer J; Bastian BC
    Dermatol Ther; 2006; 19(1):40-9. PubMed ID: 16405569
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fluorescence in situ hybridization for ambiguous melanocytic tumors.
    Gammon B; Gerami P
    Histol Histopathol; 2012 Dec; 27(12):1539-42. PubMed ID: 23059884
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence behind the use of molecular tests in melanocytic lesions and practice patterns of these tests by dermatopathologists.
    Emanuel PO; Andea AA; Vidal CI; Missall TA; Novoa RA; Bohlke AK; Hughes SR; Hurley MY; Kim J
    J Cutan Pathol; 2018 Nov; 45(11):839-846. PubMed ID: 30039879
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutation analysis in malignant melanoma.
    Gaiser MR; Stadler R; Schirmacher P; Dietel M; Enk A
    J Dtsch Dermatol Ges; 2013 May; 11 Suppl 4():2-10. PubMed ID: 23721634
    [No Abstract]   [Full Text] [Related]  

  • 16. Molecular genetic classification of difficult melanocytic tumors.
    Metzler G; Eigentler TK; Held L; Kind P; Hantschke M; Garbe C; Bauer J
    J Dtsch Dermatol Ges; 2013 May; 11 Suppl 4():11-8. PubMed ID: 23721635
    [No Abstract]   [Full Text] [Related]  

  • 17. Practical application of new technologies for melanoma diagnosis: Part II. Molecular approaches.
    March J; Hand M; Truong A; Grossman D
    J Am Acad Dermatol; 2015 Jun; 72(6):943-58; quiz 959-60. PubMed ID: 25980999
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular techniques for predicting behaviour in melanocytic neoplasms.
    Lee CY; Gerami P
    Pathology; 2016 Feb; 48(2):142-6. PubMed ID: 27020386
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atypical Spitz Tumors: A Diagnostic Challenge.
    Harms KL; Lowe L; Fullen DR; Harms PW
    Arch Pathol Lab Med; 2015 Oct; 139(10):1263-70. PubMed ID: 26414472
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Difficult to Diagnose Cutaneous Melanoma in a Patient with BAP1 Tumor Predisposition Syndrome.
    Silva-Clavería F; Álvarez-Muñoz A; Ferrándiz L; Fernández-Orland A; Conde-Martin AF; Moreno-Ramírez D; Ríos-Martín JJ
    Int J Surg Pathol; 2023 Oct; 31(7):1398-1402. PubMed ID: 36803128
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.